AustinMinicircle will sell klotho gene therapy at offshore clinics within 6 months, bypassing the Food and Drug Administration.
Evidence covers 24 people with no control group; mice with excess klotho developed bone loss, and trial data is unpublished.
No regulator covers the Bahamas, Honduras, or Panama clinics.
Sources: New Scientist